hMaxi-K

DRUG2 trials

Sponsors

Urovant Sciences GmbH

Conditions

Overactive Bladder

Phase 1

Safety Study of hMaxi-K Gene Transfer to Treat Overactive Bladder and Detrusor Overactivity

TerminatedNCT00495053

Urovant Sciences GmbHOveractive Bladder

Start: 2007-04-30End: 2009-11-30Updated: 2019-06-28

Phase 1 Study With OAB Assessing the Safety and Activity of hMaxi-K Gene Transfer

CompletedNCT01870037

Urovant Sciences GmbHOveractive Bladder

Start: 2013-01-31End: 2018-02-17Updated: 2019-05-08